100% SVR12 WITH ABT-493 AND ABT-530 WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAÏVE HCV GENOTYPE 3-INFECTED PATIENTS WITH CIRRHOSIS

Press/Media: Press / Media

PeriodApr 20 2016

Media coverage

1

Media coverage

  • Title100% SVR12 WITH ABT-493 AND ABT-530 WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAÏVE HCV GENOTYPE 3-INFECTED PATIENTS WITH CIRRHOSIS
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/20/16
    PersonsFred Poordad